Member Info for JustHereForHemo

Had alot of people selling off the back of ind who ONLY bought to sell. People assume it will happen again now? Did traders have time to buy in low again? Doubt it but time will tell :-)

The shorters had made it up to 10% yesterday on ig, could be fireworks.

Vlad put everything on hold for CAR-T, the Cork is popped and vlad now has time to deliver!

Good job Vlad, very good job, this really could destroy those traders today, absolutely fantastic. Proves everything was waiting for hemogenyx to go clinical.

I actually predicted your return today earlier on when it was obvious the blocks had stopped. Now to check for the obligatory troll tweets 🤣😂🤣

HH, Pingu, India etc, I told you he would pop up!!! Lol! Called it, so loaded up pre approval and has finished dumping, excellent!

New account, going hell for leather 19 posts in 24 hrs, no effort to hide motives or build any sort of profile first..... someone is getting desperate, 10% short on IG, what's that? About 8-10 million short shares?

Knowing that the next update is likely launch of trials or maybe PR/Interviews kicking off new buying. Must be uncomfortable.... for me I will wait, found a Spreadbet earlier when chatting to MrI, opened at like 10k a point at 1.24p like a year ago lol. For some of us waiting is nothing new and not a reason to be nervous. If your short..... Good luck!

Lol, I wonder who could it be? need to do some thinking, someone who was banned now posting obsessed with hemogenyx, need to think, but 1 and 1 together and see what I come up with :P

Haywain, are you on twitter? would love to chat some time

You do get that Hemogenyx has been well over 6p EVEN if you factor in dilution? It was quite stable 10p for a very long time before the Mint fiasco. At a time where Hemogenyx had NOTHING clinical? When CBR was still a secret and CAR-T was only in IND enabling studies? Have you any idea what Hemogenyx do or what the value of pharma is? Another pumpkin perhaps who have stumbled across a ticker and literally know nothing about the company behind it :P

Come on must be some actual Pharma investors out there lol!!!

Davie..... Well over half the population would disagree with you on that final point.... :-D However your point is well made, Mickey? I fundamentally disagree with his view and outlook but he is basing it on past experience and he is frustrated like us all. None of us can deny frustration and having a contrary viewpoint is not a bad thing. Pumpkin? Its negativity for the point of negativity. It was notable that she did not post atall last week in the lead up to the IND approval or immediately after, its only when the SP dropped back and some negativity returned that pumpkin returned. There are some posters that only appear when the SP is going up and some that only appear when its going or is down. Just shows complete lack of backbone to refuse to post when company is up and doing well lest she be called out for the preceding negativity :P

Despite what some may think, 30mil valuation for Hemogenyx is NOT realistic.

HEMO-CAR-T have just had approval to enter clinical trials, CAR-T treatments in recent years have been licenced at pre clinical, phase 1, phase 2/3 and after new drug approval. Prices for these licencing agreements are freely available, the vast majority, INCLUDING phase 1 etc, are 500m+ when you include milestone payments. HEMO-CAR-T today with the IND approval is worth easily multiples of the current mCap of Hemogenyx, when trials start IF it works the value becomes multiples and will be known within the first few patients/months.

CDX - basically this is same target market as #AVCT are aiming for, expanding chemo to many more people and reducing the toxic side effects. They want to make Chemo safer, CDX removes chemo altogether but gives same targeted results, Avct have targeted the value at billions? Same applies here, only CDX is better and because its not making EXISTING chemo safer where any revenue would be split, CDX is 100% hemogenyx (Eli Lilly will get some profits from this)

CBR - https://bnnbreaking.com/breaking-news/health/groundbreaking-mrna-therapeutics-breakthrough-room-temperature-stable-treatments-for-global-accessibility I think that makes it clear that even just the approach they have taken makes CBR as an idea worth billions, take the patented CBRs for each virus they can treat? There is no valuation high enough to cover every possibility. Will we ever see true value before its taken out of our hands? Probably not, but I can guarantee you £30m does not even scratch the surface.

100-300m valuation for a CLINICAL pharma with ANY ONE of the above would be cheap, https://sana.com/our-pipeline/ have literally an equivalent to HEMO-CAR-T and they are worth 1.55 BILLION. This current SP/mCap is just stupid, low visibility, lot of traders/shorters and lots of efforts to push the SP over the last week has successfully pushed the SP back down to a stupid price. BUT the shorters cant stay open for ever IG shows 8%, thats alot of shares that need to be bought back to close those positions, This valuation IS WRONG. The current market Valuation IS WRONG. Tick Tock, the rest of the world SLOWLY are starting to notice Hemogenyx, this will only increase as they enter Clinical Trials.

Oh so it might be worth £300 mil? So is it worth £300m or is it NOT worth £300m? Good to see your so decisive here!

So if NOT on CH being lifted when exactly should it re-rate? You do understand that lifting of CH is when the company moved from PRE-CLINICAL to CLINICAL, you know that point where the valuation DOES change?

The market is wrong and has not reacted to the lifting of the hold as it should have YET that does not make it right. My timescale is spot on, Hemogenyx ARE worth £300m+ The fact you can buy shares in it today at a fraction of that just means its currently undervalued, significantly, and it will re-rate at some point. Thats your problem Pumpkin you are 100% unable to decide for yourself what a company is worth, you just cannot do any research or any independent thought to decide what a company SHOULD be valued at.

Stick to your 10% trades, chase the rest of the sheep and continue to burn your money on dogs, I know what Hemogenyx is worth and why I am invested here which is why I sleep easy, you? You have no idea why you do anything, you just follow the herd and beach and moan constantly when you dont get to flip for your 10% straight away as you watch your life savings get taken time and again by bad trade after bad trade.

No more replies to you Pumpkin, your toxic and so far beyond hope you are just a waste of time.

Pumpkin has ZERO clue about what she is investing in, she follows the herd and gets caught up in dogs on a regular basis, for years I have asked her to value CAR-T or Hemo in general or any of the technology, target market etc. For her the fair market value is the current market value so a target of 100-300m is completely irrelevant, she values Hemogenyx at what its priced at. Which is why she will jump into a dog at 100m which should have no real value whatsoever and think its cheap because all the hype and market sentiment at that point in time says buy! AND she will tell us all about it.

I am the complete opposite, I dont care what hype and chat is on a board, if the mCap does not match up to what the company SHOULD be worth I avoid like the plague.

Basically explains why pumpkin can ONLY trade, she cant invest because she never actually knows her target because that would mean having even a ounce of comprehension of what a company is worth. The result? She buys what the herd tells her to buy, she holds and sells for 5-10% and calls herself a successful trader... OR the SP does not go up and she holds and moans for year (Hemo) or until the company goes bust and she loses the lot (If you check her trading history this happens quire frequently).

I will freely admit I am an awful trader, I dont trade, I buy and hold stock I believe in(with a few exceptions), but I jump in having an idea of what i want to get from the investment.

So pumpkin, if you DONT think mCap should be 300m? your an idiot.

Https://www.centurytx.com/clinical-trials/ 270Million again ONLY CAR-T in phase 1 trials.

Https://sana.com/our-pipeline

ONLY one item clinical, CAR-T in phase 1 trials for CLL/NHL.

Valuation?

ONE BILLION FIVE HUNDRED AND FIFTY MILLION US DOLLARS.

So yea, this mCap is so F Ed up a this point its stupid and crazy.

Woods you do realise that Hemogenyx now own 100% of HEMO-CAR-T which has been approved by the FDA to enter human trials. A company with no debt and a wide portfolio including now a nasal spray to protect against/ cure current and future viruses and some cancer. A company which is now CLINICAL. A clinical pharma with an oncology target CAR-T treatment, a treatment for a disease with high mortality where each treatment can cost 200k and most licensing deals are 500mil+ including milestones and royalty.

An mCap of 33m where we are no is a farce, its a joke, you don't need a crystal ball to know that it's unsustainable. The peers in this area with JUST CAR-T are 100-300m,the reaction over the past 3 days is inexplicable, but Hemogenyx is NOT that special, it won't remain at a 75% discount to every other CAR-T company for ever. The 8% shorts won't remain open for ever. When we start getting details about prevail and trials this SP will recover. You do not need a crystal ball to know this SP is wrong and be it a few days or weeks it will bounce hard.

FWIW it would be hilarious if after these 3 weeks of bedwetting we see a massive delayed buy drop and MMs immediately move back up again.

Anyway, I for one am incredibly impressed with what Vlad and his team have achieved and I am 100% confident that soon the market will reward his work.

Bottom line.

Shares need to move OUT of the hands of the people who spend time on LSE or discuss trading on Twitter/telegram and INTO the hands of professionals who want to invest in an early stage pharma to see it through trials. Each and every genuine shareholder should consider sharing the occasional Hemo update, it's only with increased visibility and new external investors will we see sustained recovery. Vlad is not going to do the PR so if you own part of this company and you want to support it, don't stay silent.

Fake? Here you go report it!

https://www.fda.gov/about-fda/contact-fda

Wish I knew lol, for sure Hemo is on a lot of radars now, I do know alot of people were spooked by some traders spreading placing FUD so will be alot of money playing a wait and see game. Its their choice, IMO the SP is too low to raise anything useful via placing and any actual placing will be at a premium with prevail again. If I'm right the SP will take off once doubt removed. IF I'm wrong? Vlad does a much smaller placing at 2.5p-3p shares churn just above that, once again however doubt removed and again SP takes off. This is not some oil dog that needs cash to pay 20k a day in diesel to drill exploratory holes and keep the lights on. What Hemo have, right now, today is a CAR-T treatment approved for trials, just this week a pre clinical CAR-T was licensed for MORE than the entire mCap of Hemogenyx. Word will spread, eventually, and this piece of s417 SP will correct.